Literature DB >> 2542150

Testicular atrophy in AIDS: a study of 57 autopsy cases.

M E De Paepe1, M Waxman.   

Abstract

The pertinent clinical data and histologic features of the testes in 57 autopsied acquired immunodeficiency syndrome (AIDS) patients were analyzed and compared with those of 55 age-matched control patients without AIDS. The testes of the AIDS patients showed a significantly lower degree of spermatogenesis (determined by a testicular score count), as well as more prominent thickening of the basement membrane and interstitial fibrosis when compared with the controls. While the precise cause of testicular atrophy in AIDS patients remains to be determined, the chronicity of the disease, prolonged fever, malnutrition, testicular infection, and chemotherapy are all contributing factors. Since the vast majority of the studied AIDS patients were homosexual and most control patients were heterosexual, the observed testicular changes can be ascribed to AIDS and/or homosexuality. Because of a high prevalence of sexually transmitted diseases, antisperm antibodies, and possible zinc deficiency and endocrine disorders, homosexual men appear predisposed to tubular atrophy. Conversely, AIDS-related factors, such as a direct toxic effect of the human immunodeficiency virus on germinal epithelium or as yet undetermined endocrine imbalances might exert a detrimental effect on the testis independent of homosexuality.

Entities:  

Mesh:

Year:  1989        PMID: 2542150     DOI: 10.1016/0046-8177(89)90125-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.

Authors:  Vitaly A Kushnir; William Lewis
Journal:  Fertil Steril       Date:  2011-06-30       Impact factor: 7.329

Review 2.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  Tale of Viruses in Male Infertility.

Authors:  Shreya Das; Arunima Mondal; Jayeeta Samanta; Santanu Chakraborty; Arunima Sengupta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome.

Authors:  J Pudney; D Anderson
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

Review 5.  Male fertility and skin diseases.

Authors:  M Badawy Abdel-Naser; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 9.306

6.  Endocrine alterations in HIV-infected patients.

Authors:  Sujit Kumar Tripathy; Ritesh Kumar Agrawala; Anoj Kumar Baliarsinha
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

7.  A study on hypogonadism in male HIV patients in northeastern part of India.

Authors:  Nungsangla Pongener; Ranabir Salam; Robinson Ningshen; Vizovonuo Visi; Tamphasana Wairokpam; L Shaini Devi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2019 Jan-Jun

8.  Glucose Metabolism Disorder Induces Spermatogenic Dysfunction in Northern Pig-Tailed Macaques (Macaca leonina) With Long-Term SIVmac239 Infection.

Authors:  Tian-Zhang Song; Ming-Xu Zhang; Han-Dan Zhang; Xue-Hui Wang; Wei Pang; Ren-Rong Tian; Yong-Tang Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-24       Impact factor: 5.555

Review 9.  Diabetes as a potential compounding factor in COVID-19-mediated male subfertility.

Authors:  Qingkui Jiang; Thomas Linn; Karl Drlica; Lanbo Shi
Journal:  Cell Biosci       Date:  2022-03-20       Impact factor: 9.584

10.  Viral infections and implications for male reproductive health.

Authors:  Thiago A Teixeira; Yasmin C Oliveira; Felipe S Bernardes; Esper G Kallas; Amaro N Duarte-Neto; Sandro C Esteves; Joël R Drevet; Jorge Hallak
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.